Exosome Diagnostics
Kelli Neary is an experienced professional in the healthcare and pharmaceutical sectors, currently serving as a Senior Account Representative at Exosome Diagnostics since June 2019. Prior to this role, Kelli worked as an Immunology Account Manager at Merck from March 2018 to June 2019. Kelli's career also includes a significant tenure at Endo International plc from January 2006 to January 2017, where Kelli held positions as District Manager and Urology Sales Specialist, focusing on pain, urology, endocrinology, and oncology products. Kelli’s early career included serving as an Account Representative for the American Red Cross from January 2003 to December 2005. Kelli holds a Bachelor's degree in Business, Management, Marketing, and Related Support Services from Towson University, earned between 1998 and 2002.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.